Fri, Aug 22, 2014, 5:28 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Novadaq Technologies Inc. Message Board

is_thisdifferent 2 posts  |  Last Activity: Aug 18, 2014 6:39 PM Member since: Jul 9, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    BIO MED Takeovers

    by kkllfla Aug 18, 2014 9:01 AM
    is_thisdifferent is_thisdifferent Aug 18, 2014 6:39 PM Flag

    I hope for there employees they sell, because if they think this management team has what it takes to skyrocket, well they are wrong. This stock is like the whole market, way way overvalued. Take away Lifecell and Intuitive Novadaqs direct sales force has made a small fraction of sales in the US. Thank goodness they have a great International team, otherwise they would have more dancing to do during there quartly cc calls!

  • Reply to

    what should not be overlooked

    by e11ndofwar Aug 14, 2014 3:44 PM
    is_thisdifferent is_thisdifferent Aug 15, 2014 3:52 PM Flag

    I think that have tapped out on the breast surgery. Hospitals don't get reimbursement for SPY so it makes it challenging to grown. Not to mention competition in the open SPY and wound care is coming. A French company will soon be ready to go after these. If it does what SPY is and is less expensive boom the knife will fall. SInce most of LifeCell's business is placements not capital. I think this company has a lot of smoke and mirrors. By the time they get approval on Lymphnode mapping Olympus/Storz will have the same technology. Its time to call a spade a spade. For years the CEO has told us standard of care or x number of operations and has it come true? NOPE. Time to quit letting wallstreet say buy buy buy, before they dump there shares on you. Take my read with a grain of salt if you want, but this CEO has poor direct sales leadership in the US and with that is a recipe for disaster.

14.60-0.29(-1.95%)Aug 22 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.